taurolithocholic acid

Taurolithocholic acid 3-sulfate (TLC-S) induces Ca²⁺ signaling in isolated murine pancreatic acinar cells (PACs). Ca²⁺ oscillations occur at concentrations as low as 25 μM and are triggered in nearly all cells at 200 μM. At 300–500 μM, Taurolithocholic produces prolonged Ca²⁺ elevations that begin with intracellular Ca²⁺ release and are sustained by extracellular Ca²⁺ influx. Other bile salts, including taurodeoxycholate (TDC) and taurocholate (TC), can also stimulate local and global Ca²⁺ oscillations but only at much higher concentrations (approximately 1 mM and 5 mM). Taurolithocholic is a potent Ca²⁺-releasing bile acid tested in PACs and is uniquely effective at inducing Ca²⁺-independent ionic currents even at low micromolar levels. Therefore implicating Taurolithocholic as a strong canidate for researches in gut metabolism.

Taurolithocholic Acid 3-sulfate sodium salt is a GPR39 agonist. In the absence of Zn²⁺, its EC50 values are 71.6 μM and 69.4 μM in M39-20 and hGPR39-2 cells, respectively; in the presence of Zn²⁺, the values are 9 μM and 9.6 μM, respectively. Taurolithocholic Acid 3-sulfate sodium salt activates the GPR39 receptor and mediates intracellular calcium signaling pathways independently of the Zn²⁺-binding sites H17 and H19, and can be used in research on gallbladder-related diseases.

Taurolithocholic acid sodium salt (Sodium taurolithocholate) is the major human metabolite, a bile acid which inhibits radioligand binding to muscarinic M1, but not to M2 or M3 receptors.

Taurolithocholic Acid-D5 Sodium Salt (Major) is a deuterated compound of Taurolithocholic Acid Sodium Salt. Taurolithocholic Acid Sodium Salt (T4727) has a CAS number of 6042-32-6. The major human metabolite, a bile acid which inhibits radioligand binding to muscarinic M1, but not to M2 or M3 receptors.

Taurolithocholic acid sodium salt (Standard) is a reference standard for research and analysis in studies involving Taurolithocholic acid sodium salt. Taurolithocholic acid sodium salt (Sodium taurolithocholate) is the major human metabolite, a bile acid which inhibits radioligand binding to muscarinic M1, but not to M2 or M3 receptors.

Taurolithocholic Acid 3-sulfate (sodium salt) (Standard) is a reference standard for research and analysis in studies involving Taurolithocholic Acid 3-sulfate (sodium salt). Taurolithocholic acid 3-sulfate (TLCA3S) is a metabolite of the conjugated bile acid taurolithocholic acid . TLCA3S has been used to study bile acid transport in cellular models and to induce pancreatitis in mouse models of bile acid infusion pancreatitis.

Taurolithocholic Acid-[D4] Sodium Salt (Standard) is a reference standard of Taurolithocholic Acid-[D4] Sodium Salt intended for quantitative analysis, quality control, and related biochemical research applications.

Taurolithocholic Acid-[D4]-3-Sulfate Sodium Salt (Standard) is a reference standard of Taurolithocholic Acid-[D4]-3-Sulfate Sodium Salt intended for quantitative analysis, quality control, and related biochemical research applications.

12-Hydroxy Taurolithocholic Acid Sulfate Disodium Salt is applicable for lipid research.

Taurohyocholic acid (THCA) is a taurine-conjugated form of the porcine-specific primary bile acid hyocholic acid .1THCA inhibits precipitation of cholesterol crystals by stabilizing cholesterol in the liquid-crystalline phase.2It prevents cholestasis and cellular necrosis induced by taurolithocholic acid in isolated rat livers.3THCA levels are increased in the urine of patients with hepatitis B-induced cirrhosis.4

Taurohyocholic acid (THCA), a taurine-conjugated form of porcine-specific primary bile acid hyocholic acid, inhibits cholesterol crystal precipitation by stabilizing cholesterol in the liquid-crystalline phase and prevents cholestasis and cellular necrosis in isolated rat livers induced by taurolithocholic acid. Additionally, THCA levels rise in the urine of patients with hepatitis B-induced cirrhosis.

Taurohyocholic Acid sodium (Standard) is a reference standard for research and analysis in studies involving Taurohyocholic Acid sodium. Taurohyocholic acid (THCA), a taurine-conjugated form of porcine-specific primary bile acid hyocholic acid, inhibits cholesterol crystal precipitation by stabilizing cholesterol in the liquid-crystalline phase and prevents cholestasis and cellular necrosis in isolated rat livers induced by taurolithocholic acid. Additionally, THCA levels rise in the urine of patients with hepatitis B-induced cirrhosis.

Tauroisolithocholanoic acid sodium is an isomer of the naturally occurring Taurolithocholic acid.